Health Canada releases guidance documents for subsequent entry biologics.
Robertson
Scott
S
Gowling Lafleur Henderson LLP, Ottawa.
D001688:Biological Products / Q000592:standards*; D002170:Canada; D033161:Government Regulation; D007880:Legislation, Drug; D009313:National Health Programs
D001688:Biological Products